Brushing Away Oral Cancer | Medical News and Health Information

Reported August 3, 2011

Brushing Away Oral Cancer -- Research Summary

BACKGROUND: Oral cancer is cancer of the mouth. An estimated 350,000 to 400,000 new cases are diagnosed each year. Approximately half of people with oral cancer will live more than 5 years after they are diagnosed and treated. If the cancer is found early, before it has spread to other tissues, the cure rate is nearly 90 percent. However, more than half of oral cancers have already spread when the cancer is detected. Most have spread to the throat or neck. About 1 in 4 persons with oral cancer die because of delayed diagnosis and treatment. (SOURCE: PubMed Health)

CARCINOMA: Carcinomas are malignancies that originate in the epithelial tissues. Epithelial cells cover the external surface of the body, line the internal cavities, and form the lining of glandular tissues. The incidence of oral tongue squamous cell carcinoma has been rising in young white American women, according to a new report. For the past three decades, the incidence has been increasing in white men and white women 18 to 44 years of age, but the trend is most pronounced in young white women.

EARLY TESTING: The OralCDx BrushTest is an easy, painless and definitive way for doctors to test the common small white and red oral spots that most people have in their mouth at one time or another. The BrushTest is used to determine if a common oral spot contains abnormal cells (known as dysplasia) that, if left alone for several years, may develop into oral cancer.

It typically takes several years before a dysplastic oral spot can turn into an oral cancer, and during this time, the spot can be removed, and oral cancer can potentially be prevented from even starting. OralCDx consists of a specially-designed brush that is used to painlessly obtain a sample of an oral lesion. In contrast to a typical cytologic smear, like a Pap smear, which samples cells only from the superficial layer, the OralCDx brush obtains a complete transepithelial biopsy specimen by collecting cells from all three layers of the epithelium: the superficial, intermediate and the basal layer. OralCDx requires no anesthesia, causes no pain and is associated with minimal or no bleeding. (SOURCE: OralCDx) MORE ► Brushing Away Oral Cancer -- Research Summary | Medical News and Health Information: "Reported August 3, 2011 and ► Brushing Away Oral Cancer | Medical News and Health Information: "- Enviado mediante la barra Google"

FOR MORE INFORMATION, PLEASE CONTACT:
Eric Hirsch, Public Relations
OralCDx Laboratories
ehirsch@oralcdx.com

first step ► Brushing Away Oral Cancer | Medical News and Health Information: "- Enviado mediante la barra Google"